- Home
- Publications
- Publication Search
- Publication Details
Title
One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-01
DOI
10.3389/fimmu.2021.618710
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia
- (2020) Xin He et al. BLOOD
- Acute myeloid leukemia immune escape by epigenetic CD48 silencing
- (2020) Zhiding Wang et al. CLINICAL SCIENCE
- Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients
- (2020) Kangni Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in MDS and AML patients: Phase Ib results.
- (2020) David Andrew Sallman et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
- (2020) Carsten Riether et al. NATURE MEDICINE
- TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation
- (2020) Tram N. Dao et al. Cancers
- Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy
- (2019) Paola Dama et al. Journal for ImmunoTherapy of Cancer
- Tim-3 Promotes Listeria monocytogenes Immune Evasion by Suppressing Major Histocompatibility Complex Class I
- (2019) Zhiding Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Tim-3 hampers tumor surveillance of liver resident and conventional NK cells by disrupting PI3K signaling
- (2019) Siyu Tan et al. CANCER RESEARCH
- TIM-3 Regulates CD103 + Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
- (2018) Álvaro de Mingo Pulido et al. CANCER CELL
- Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance
- (2018) Inna M. Yasinska et al. Cellular & Molecular Immunology
- Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
- (2018) S. Haubner et al. LEUKEMIA
- CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection
- (2018) Vishal Khairnar et al. Nature Communications
- Acute myeloid leukaemia
- (2018) Nicholas J Short et al. LANCET
- Evaluation of the effect of TIM-3 suppression by miR-498 and its effect on apoptosis and proliferation rate of HL-60 cell line
- (2018) Yaser Moghaddam et al. PATHOLOGY RESEARCH AND PRACTICE
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
- (2017) Wenwen Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
- (2017) Isabel Gonçalves Silva et al. EBioMedicine
- Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2
- (2017) Zhiding Wang et al. Scientific Reports
- Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p
- (2016) Haniyeh Fooladinezhad et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts
- (2016) Su Li Poh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro
- (2016) Fatemeh Emamdoost et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro
- (2016) Fatemeh Emamdoost et al. Indian Journal of Hematology and Blood Transfusion
- The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
- (2016) Isabel Gonçalves Silva et al. OncoImmunology
- A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression
- (2015) Yoshikane Kikushige et al. Cell Stem Cell
- The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells
- (2015) Alexandr Prokhorov et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation
- (2015) Binh L. Phong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells
- (2015) Valentina Folgiero et al. Journal of Hematology & Oncology
- Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia
- (2015) Yoshikane Kikushige et al. ONCOLOGY
- Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells
- (2015) Isabel Gonçalves Silva et al. Oncotarget
- Tim-3 and Tim-4 as the potential targets for antitumor therapy
- (2015) Lin Cheng et al. Human Vaccines & Immunotherapeutics
- Hypothesis: Tim-3/Galectin-9, A New Pathway for Leukemia Stem Cells Survival by Promoting Expansion of Myeloid-Derived Suppressor Cells and Differentiating into Tumor-Associated Macrophages
- (2014) Lei Gao et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- Enhanced Virus-Specific CD8+ T Cell Responses by Listeria monocytogenes-Infected Dendritic Cells in the Context of Tim-3 Blockade
- (2014) Cheng J. Ma et al. PLoS One
- T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
- (2013) X. Yang et al. JOURNAL OF IMMUNOLOGY
- Tim-3 Expression Defines Regulatory T Cells in Human Tumors
- (2013) Jing Yan et al. PLoS One
- TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia
- (2012) Yoshikane Kikushige et al. Annals of the New York Academy of Sciences
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- (2012) L. C. Ndhlovu et al. BLOOD
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- (2012) M. K. Gleason et al. BLOOD
- Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas
- (2012) Muhammad Baghdadi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Acute myelogenous leukemia stem cells: From Bench to Bedside
- (2012) J. Felipe Rico et al. CANCER LETTERS
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
- (2012) M. Jan et al. Science Translational Medicine
- Effects of Stem Cell Factor on Hypoxia-Inducible Factor 1 Alpha Accumulation in Human Acute Myeloid Leukaemia and LAD2 Mast Cells
- (2011) Bernhard F. Gibbs et al. PLoS One
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
- (2010) H.-T. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Wnt/ -Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
- (2010) Y. Wang et al. SCIENCE
- Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
- (2009) M. Nakayama et al. BLOOD
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- (2009) James F Curtin et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started